BESHAR LUKE M 4
4 · Omega Therapeutics, Inc. · Filed Jul 30, 2021
Insider Transaction Report
Form 4
BESHAR LUKE M
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-29+52,941→ 52,941 totalExercise: $17.00Exp: 2031-07-28→ Common Stock (52,941 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on June 2, 2022 and in 36 equal monthly installments thereafter such that the option will become fully vested and exercisable on June 22, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.